Regulations to centrally clear OTC
derivatives are currently being implemented in the US, while European
regulators are still negotiating the final form of regulation in the EU. The
moves follow the agreement by the Group of 20 countries to improve reporting
and reduce bilateral clearing arrangements in derivatives, which were seen as
being partly responsible for the financial crisis in 2008.